NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

SBTDC logo
North Carolina entrepreneurs on the prowl for equity funding will get some professional help this Thursday, July 11, as  the North Carolina Biotechnology Center hosts the Small Business and Technology Development Center’s "Becoming an Investor-Ready Entrepreneur" program.
ViiV Healthcare, a global HIV company with U.S. headquarters in RTP, gets EU okay to begin marketing its once-daily Dovato, previously approved for the U.S.
Event logo
North Carolina is ready to lead in military medical technology, said Scott Dorney, head of the NC Military Business Center, to attendees at the 2019 Warfighter symposium in Chapel Hill.
CivaTech logo
RTP's CivaTech Oncology has some rare good news about pancreatic cancer.
Support to the Warfighter graphic
Navigating the maze of 20 different organizations that approve military technology projects for funding can be daunting. The 2019 Support to the Warfighter Symposium speakers offered some roadmaps for submitting successful project proposals.
Milestone logo
Milestone Pharmaceuticals, a Montreal company with a growing Charlotte subsidiary, has something in development that investors like: a nasal spray called Etripamil, in Phase 3 clinical trials to treat a form of heart arrhythmia.
NOAA logo
Climate held sway at this year's annual Ag Tech Professional Forum Summer Social, where like-minded people networked and learned.
Syngenta logo
In speculating about the future of agriculture, David Hollinrake, president of Syngenta Seeds and North America region director, is certain of one thing: “It’s not going to be my daddy’s farm moving forward.”
NC Research Campus logo
SNP Therapeutics, an innovative Charlotte-area company, is merging high-tech genomic testing with personalized nutritional formulations to treat individual medical conditions.
Mycovia
Durham’s Mycovia Pharmaceuticals and Jiangsu Hengrui Medicine of China have announced a collaboration to develop and commercialize Mycovia’s drug candidate for treating recurrent yeast infections in women.
Triad BioNight loto
Some of the Piedmont Triad’s most successful individuals and organizations working in the biosciences were honored with Excellence Awards at Triad BioNight.
Sage Therapeutics logo
Sage Therapeutics, a Boston-area biopharmaceutical company, has declared Raleigh its “second home” while opening a groundbreaking patient-support headquarters here called Sage Central.
Military procurement leaders at the 2019 Medical, Biomedical, & Biodefense Support to the Warfigher Symposium said the U.S. Joint Forces Command are actively seeking private sector partners to develop new and innovative technology to support the health and healing of U.S. warfighters and veterans.
Tergus Pharma logo
Durham-based Tergus Pharma expects to add 200 workers over the next five years after it converts a newly acquired 100,000-square-foot building into a new headquarters and commercial manufacturing facility. 

By Barry Teater, NCBiotech Writer

North Carolina State University (NCSU) will lead a new $30 million research program intended to make crops more resilient against environmental stresses while reducing the need for chemical treatments and irrigation.

NCSU will receive about $8 million of the program’s funding over six years to study how microbes in soil, roots and leaves interact with plants and affect plant health and productivity.